Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Intratumoral heterogeneity in cancer progression and response to immunotherapy

1 Feb 2021

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Cancer Immunotherapy and Biomarkers
Share to Ferroptosis and cancer prognosis

Source

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Identifiers

PMID: 33574607
DOI: 10.1038/s41591-021-01233-9

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 20 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Intratumoral heterogeneity in cancer progression and response to immunotherapyPMID 33574607Read ↗

Biological and Therapeutic Impact of Intratumor Heterogeneity in Cancer EvolutionSemantic proximity Read ↗

Intratumor heterogeneity reflects clinical disease courseSemantic proximity Read ↗

Intratumoral Heterogeneity: More Than Just MutationsSemantic proximity Read ↗

Cellular Mechanisms Underlying Intertumoral HeterogeneitySemantic proximity Read ↗

Intratumor Heterogeneity: The Rosetta Stone of Therapy Resistance.Semantic proximity Read ↗

Intratumoral Heterogeneity: From Diversity Comes ResistanceSemantic proximity Read ↗

[Intratumor heterogeneity, a Darwinian stumbling block towards personalized medicine?].Semantic proximity Read ↗

Clinical implications of intratumor heterogeneity: challenges and opportunities.Semantic proximity Read ↗

Intratumoral heterogeneity as a predictive biomarker in anti-PD-(L)1 therapies for non-small cell lung cancerSemantic proximity Read ↗

Intratumoral heterogeneity: pathways to treatment resistance and relapse in human glioblastomaSemantic proximity Read ↗

Intra-tumor heterogeneity of cancer cells and its implications for cancer treatment.Semantic proximity Read ↗

Cancer heterogeneity: implications for targeted therapeuticsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.